265 related articles for article (PubMed ID: 16751266)
1. Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice.
Klinakis A; Szabolcs M; Politi K; Kiaris H; Artavanis-Tsakonas S; Efstratiadis A
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9262-7. PubMed ID: 16751266
[TBL] [Abstract][Full Text] [Related]
2. Notch, Myc and breast cancer.
Efstratiadis A; Szabolcs M; Klinakis A
Cell Cycle; 2007 Feb; 6(4):418-29. PubMed ID: 17329972
[TBL] [Abstract][Full Text] [Related]
3. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
5. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
6. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
[TBL] [Abstract][Full Text] [Related]
7. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
Ling H; Sylvestre JR; Jolicoeur P
Oncogene; 2010 Aug; 29(32):4543-54. PubMed ID: 20562911
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
[TBL] [Abstract][Full Text] [Related]
9. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.
Palomero T; Lim WK; Odom DT; Sulis ML; Real PJ; Margolin A; Barnes KC; O'Neil J; Neuberg D; Weng AP; Aster JC; Sigaux F; Soulier J; Look AT; Young RA; Califano A; Ferrando AA
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18261-6. PubMed ID: 17114293
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
Hu C; Diévart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
[TBL] [Abstract][Full Text] [Related]
11. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.
D'Cruz CM; Gunther EJ; Boxer RB; Hartman JL; Sintasath L; Moody SE; Cox JD; Ha SI; Belka GK; Golant A; Cardiff RD; Chodosh LA
Nat Med; 2001 Feb; 7(2):235-9. PubMed ID: 11175856
[TBL] [Abstract][Full Text] [Related]
12. Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis.
Jang JW; Boxer RB; Chodosh LA
Mol Cell Biol; 2006 Nov; 26(21):8109-21. PubMed ID: 16908535
[TBL] [Abstract][Full Text] [Related]
13. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.
Moumen M; Chiche A; Decraene C; Petit V; Gandarillas A; Deugnier MA; Glukhova MA; Faraldo MM
Mol Cancer; 2013 Oct; 12(1):132. PubMed ID: 24171719
[TBL] [Abstract][Full Text] [Related]
14. Structurally distinct ligand-binding or ligand-independent Notch1 mutants are leukemogenic but affect thymocyte development, apoptosis, and metastasis differently.
Priceputu E; Bouallaga I; Zhang Y; Li X; Chrobak P; Hanna ZS; Poudrier J; Kay DG; Jolicoeur P
J Immunol; 2006 Aug; 177(4):2153-66. PubMed ID: 16887975
[TBL] [Abstract][Full Text] [Related]
15. Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium.
Kiaris H; Politi K; Grimm LM; Szabolcs M; Fisher P; Efstratiadis A; Artavanis-Tsakonas S
Am J Pathol; 2004 Aug; 165(2):695-705. PubMed ID: 15277242
[TBL] [Abstract][Full Text] [Related]
16. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
17. Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cells.
Boyle ST; Gieniec KA; Gregor CE; Faulkner JW; McColl SR; Kochetkova M
Mol Cancer; 2017 Jan; 16(1):19. PubMed ID: 28137279
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
19. Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise.
Ling H; Jolicoeur P
Oncogene; 2013 Jul; 32(29):3410-9. PubMed ID: 22907433
[TBL] [Abstract][Full Text] [Related]
20. Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism.
Mohapatra BC; Mirza S; Bele A; Gurumurthy CB; Raza M; Saleem I; Storck MD; Sarkar A; Kollala SS; Shukla SK; Southekal S; Wagner KU; Qiu F; Lele SM; Alsaleem MA; Rakha EA; Guda C; Singh PK; Cardiff RD; Band H; Band V
Mol Cancer Res; 2022 Sep; 20(9):1391-1404. PubMed ID: 35675041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
